Innova Captab

864.60
+8.50
(0.99%)
Market Cap
4,947.67 Cr
EPS
22.41
PE Ratio
38.22
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
1,260.00
52 Week Low
495.00
PB Ratio
5.11
Debt to Equity
0.38
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from2 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,674.00
#1 4,01,648.67
35.11
#1 52,041.20
12.06
#1 10,980
-18.99
49.60
6,899.00
1,83,146.77
83.20
9,360.00
0.89
2,117
23.05
67.24
1,512.40
1,22,157.73
23.68
28,409.50
7.12
5,291
30.28
52.75
3,347.80
1,13,304.76
58.56
11,317.00
11.59
2,054
10.91
59.08
1,290.10
1,07,668.02
19.45
33,741.20
12.36
5,725
21.14
49.51
1,001.65
1,00,789.43
21.53
22,573.80
13.82
3,977
-0.19
69.48
2,386.90
98,514.22
49.11
12,207.40
19.57
1,925
-10.91
49.97
1,967.30
89,845.70
27.22
22,192.10
#1 19.94
3,024
#1 112.49
47.26
35,290.00
74,988.79
53.31
6,409.15
10.80
1,417
27.83
71.69
1,172.00
68,069.95
#1 19.42
31,378.10
17.55
3,366
-0.50
55.14

Automatic Screeners on ScanX

Forecast
Actual
Growth Rate
Revenue Growth
16.91 %
Net Income Growth
38.68 %
Cash Flow Change
118.03 %
ROE
-53.82 %
ROCE
-45.34 %
EBITDA Margin (Avg.)
16.22 %

Quarterly Financial Results

Quarterly Financials
Mar 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Revenue
217
244
245
244
234
286
305
268
296
320
321
318
Expenses
197
211
208
214
202
243
258
225
252
269
270
267
EBITDA
21
33
37
29
32
44
47
44
44
52
51
51
Operating Profit %
9 %
13 %
14 %
11 %
13 %
14 %
15 %
15 %
14 %
16 %
15 %
15 %
Depreciation
3
3
3
3
3
5
5
3
5
5
5
10
Interest
3
5
6
5
5
9
7
1
0
0
0
2
Profit Before Tax
15
25
28
21
25
30
35
40
39
47
46
39
Tax
2
6
9
4
7
7
10
11
10
12
11
10
Net Profit
13
19
20
17
18
23
25
29
30
35
34
30
EPS in ₹
108.91
3.91
4.08
3.59
3.67
4.77
4.39
5.02
5.15
6.12
5.97
5.17

Balance Sheet

Balance Sheet
2019
2020
2021
2022
2023
2024
2025
Total Assets
223
245
370
576
704
1,321
1,580
Fixed Assets
79
73
79
183
183
358
836
Current Assets
143
171
271
379
443
580
703
Capital Work in Progress
0
0
7
0
22
341
23
Investments
0
0
0
0
0
0
208
Other Assets
145
172
283
392
500
622
0
Total Liabilities
223
245
370
576
704
1,321
1,580
Current Liabilities
112
120
215
295
278
266
353
Non Current Liabilities
28
14
10
72
150
225
268
Total Equity
83
110
145
209
277
831
959
Reserve & Surplus
71
98
133
197
229
774
902
Share Capital
12
12
12
12
48
57
57

Cash Flow

Cash Flow
2019
2020
2021
2022
2023
2024
Net Cash Flow
1
2
3
-5
3
8
Investing Activities
-9
-6
-20
-188
-91
-499
Operating Activities
19
31
42
59
67
146
Financing Activities
-9
-23
-19
125
27
361

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
31 Jul 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
31 Jul 2025 846.95 856.10
19 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
19 May 2025 932.00 922.75
05 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
05 Feb 2025 954.00 1,007.95
07 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Nov 2024 733.60 858.70
18 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
18 Sept 2024 692.15 805.75

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication1 day ago
Closure of Trading Window8 days ago
Gift Of SharesJun 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 26, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 21, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 20, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 19, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 19, 2025
Shifting Of Registered OfficeMay 19, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 19, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. 19Th May 2025May 19, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 15, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 13, 2025
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For Consideration Of Audited Financial Results For The Quarter And Year Ended March 31 2025.May 12, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportApr 25, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 12, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Closure of Trading WindowMar 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 01, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 26, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Feb 14, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 13, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 11, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 06, 2025
Integrated Filing (Financial)Feb 05, 2025
Statement For Deviation(S) Or Variation(S) Pursuant To Regulation 32 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Quarter EnFeb 05, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 05, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 05, 2025
Approval Of The Un-Audited (Standalone And Consolidated) Financial Results For The Quarter And Nine Months Ended December 31 2024Feb 05, 2025
Integrated Filing (Financial)Feb 05, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. February 05 2025Feb 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 30, 2025
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For Consideration Of Un-Audited Financial ReJan 29, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Sale Of Property Of Sharon Bio-Medicine Limited Material Subsidiary Of The Company.Jan 20, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -Shifting Of Registered Office Of Sharon Bio-Medicine Limited Material Subsidiary Of The CompaJan 20, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 14, 2025
Disclosure under Regulation 30A of LODRJan 14, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 02, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 23, 2024
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 14, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 12, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 12, 2024
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportNov 11, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 08, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 08, 2024

Technical Indicators

RSI(14)
Neutral
46.54
ATR(14)
Less Volatile
33.23
STOCH(9,6)
Neutral
36.95
STOCH RSI(14)
Neutral
33.10
MACD(12,26)
Bearish
-1.03
ADX(14)
Weak Trend
13.22
UO(9)
Bearish
41.54
ROC(12)
Downtrend And Accelerating
-2.41
WillR(14)
Neutral
-69.61

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Edelweiss Recently Listed IPO Fund Direct-Growth
1.28%
-50000
-0.61%
-0.74%
Kotak Healthcare Fund Direct - Growth
1.86%
35395
0.65%
0.79%
Canara Robeco Small Cap Fund Direct - Growth
1.15%
20000
-0.08%
-0.10%
Samco Multi Cap Fund Direct-Growth
0.28%
11642
0.28%
0.28%
Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth
0.18%
2873
-0.02%
-0.03%
Angel One Nifty Total Market Index Fund Direct - Growth
0.01%
2
0.00%
0.00%
Mirae Asset Nifty Total Market Index Fund Direct-Growth
0.01%
1
0.00%
0.00%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.11%
0
0.00%
0.00%
Canara Robeco Value Fund Direct - Growth
1.13%
0
-0.05%
-0.07%
Groww Nifty Total Market Index Fund Direct - Growth
0.01%
0
0.00%
0.00%
Invesco India Manufacturing Fund Direct-Growth
0.86%
0
-0.06%
-0.08%
Invesco India Mid Cap Fund Direct-Growth
1.15%
0
-0.13%
-0.18%
Invesco India Smallcap Fund Direct - Growth
0.81%
0
-0.09%
-0.12%
Kotak Consumption Fund Direct - Growth
1.55%
0
-0.06%
-0.10%
Canara Robeco Conservative Hybrid Fund Direct-Growth
0.00%
0
0.00%
0.00%
Kotak Multicap Fund Direct - Growth
0.88%
0
-0.06%
-0.11%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.01%
0
0.00%
0.00%
Bandhan Small Cap Fund Direct-Growth
0.20%
0
-0.03%
-0.04%
Canara Robeco Manufacturing Fund Direct - Growth
1.47%
0
-0.09%
-0.11%
TRUSTMF Small Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
WhiteOak Capital ELSS Tax Saver Fund Direct - Growth
0.00%
0
0.00%
0.00%
WhiteOak Capital Flexi Cap Fund Direct - Growth
0.00%
0
0.00%
0.00%
WhiteOak Capital Mid Cap Fund Direct - Growth
0.00%
0
0.00%
0.00%
WhiteOak Capital Multi Cap Fund Direct - Growth
0.00%
0
0.00%
0.00%
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth
0.00%
0
0.00%
0.00%